SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001062993-20-006520
Filing Date
2020-12-22
Accepted
2020-12-22 15:05:51
Documents
7
Period of Report
2019-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 6-K form6k.htm 6-K 5916
2 EXHIBIT 99.1 exhibit99-1.htm EX-99.1 8061
3 EXHIBIT 99.2 exhibit99-2.htm EX-99.2 561542
4 EXHIBIT 99.3 exhibit99-3.htm EX-99.3 195501
5 EXHIBIT 99.4 exhibit99-4.htm EX-99.4 5624
6 EXHIBIT 99.5 exhibit99-5.htm EX-99.5 5411
7 GRAPHIC exhibit99-1x001.jpg GRAPHIC 3396
  Complete submission text file 0001062993-20-006520.txt   788216
Mailing Address SUITE 900 - 570 GRANVILLE STREET VANCOUVER BC A1 V6C 3P1
Business Address SUITE 900 - 570 GRANVILLE STREET VANCOUVER BC A1 V6C 3P1 604-248-8693
REPLICEL LIFE SCIENCES INC. (Filer) CIK: 0001205059 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 000-50112 | Film No.: 201407732
SIC: 2836 Biological Products, (No Diagnostic Substances)